| Cue Energy Resources Limited (CUE) ORDINARY FULLY PAID |
Energy |
$77 |
ECH: ECHELON SIGNS TERM SHEET TO UNLOCK NT GROWTH
|
15 Dec 2025 9:35AM |
$0.110 |
$0.110 |
fallen by
0%
|
|
CUE - Price-sensitive ASX Announcement
Full Release
Key Points
- Echelon signs non-binding term sheet with Northern Territory's PWC.
- Agreement is for gas sale from Mereenie and Palm Valley fields till 2034.
- Firm supply of 19.1 PJ, with additional 13.3 PJ from new wells.
- Four new wells to be drilled: two at Mereenie and two at Palm Valley.
- Enhanced gas output to address Northern Territory's supply constraints.
- Participants include Central Petroleum, Echelon, Cue Energy Resources, and Horizon Australia Energy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Echelon Resources Limited (ECH) ORDINARY FULLY PAID |
Energy |
$77 |
ECHELON SIGNS TERM SHEET TO UNLOCK NT GROWTH
|
15 Dec 2025 9:35AM |
$0.345 |
$0.345 |
fallen by
0%
|
|
ECH - Price-sensitive ASX Announcement
Full Release
Key Points
- Echelon Resources Limited has signed a term sheet with the Northern Territory's Power and Water Corporation to sell gas from Mereenie and Palm Valley fields.
- The agreement involves non-binding terms for a firm supply of up to 19.1 PJ of gas, with plans for drilling four new development wells.
- The new wells aim to add up to 13.3 PJ of additional gas supply.
- The initiative is expected to boost gas output from the Amadeus Basin and address supply constraints in the Northern Territory.
- Echelon’s CEO highlights the agreement as a significant growth opportunity.
- Participants in the Mereenie permits include Central Petroleum, Echelon Mereenie Pty Ltd, Cue Mereenie Pty Ltd, and Horizon Australia Energy Pty Ltd.
- Participants in the Palm Valley permit include Central Petroleum, Echelon Palm Valley Pty Ltd, and Cue Palm Valley Pty Ltd.
- Echelon Resources Limited is focused on ethical and values-based energy commodity exploration and production.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Horizon Oil Limited (HZN) ORDINARY FULLY PAID |
Energy |
$317 |
ECH: ECHELON SIGNS TERM SHEET TO UNLOCK NT GROWTH
|
15 Dec 2025 9:35AM |
$0.205 |
$0.195 |
fallen by
4.88%
|
|
HZN - Price-sensitive ASX Announcement
Full Release
Key Points
- Echelon signs term sheet for gas sale with Power and Water Corporation.
- Agreement covers gas supply from Mereenie and Palm Valley fields to 2034.
- The project involves drilling four new wells, enhancing gas supply.
- Horizon Australia Energy Pty Ltd holds a 25% stake in Mereenie.
- The arrangement aims to increase gas supply and support Northern Territory's power reliability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| National Storage REIT (NSR) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$3,903 |
Disclosure under Takeovers Panel GN 20 - Equity Derivatives
|
15 Dec 2025 9:35AM |
$2.780 |
$2.780 |
fallen by
0%
|
|
| Radiopharm Theranostics Limited (RAD) ORDINARY FULLY PAID |
Health Care |
$103 |
RAD101 interim Phase 2b data - 92% achieve primary endpoint
|
15 Dec 2025 9:35AM |
$0.019 |
$0.029 |
risen by
52.63%
|
|
RAD - Price-sensitive ASX Announcement
Full Release
Key Points
- Radiopharm Theranostics announced that 92% of patients in the interim Phase 2b trial for RAD101 achieved the primary endpoint of concordance with MRI.
- RAD101 is a novel imaging agent targeting fatty acid synthase (FASN) and is radiolabeled with Fluorine-18.
- The trial is focused on diagnosing suspected recurrent brain metastases from solid tumors.
- The results showed significant and selective tumor uptake in brain metastases.
- The company plans to initiate a pivotal study by the end of 2026.
- RAD101 has a potential U.S. market opportunity of over $500 million annually.
- Radiopharm Theranostics is a clinical-stage biopharmaceutical company focused on oncology radiopharmaceuticals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dart Mining NL (DTM) ORDINARY FULLY PAID |
Materials |
$9 |
Highest Gold Results Received at Banshee Antimony Mine
|
15 Dec 2025 9:33AM |
$0.035 |
$0.041 |
risen by
17.14%
|
|
DTM - Price-sensitive ASX Announcement
Full Release
Key Points
- Drill hole CBADD002 at Banshee returned the highest gold assay to date.
- Assay results from CBADD002 include 0.5m at 18.30 g/t Au from 184.5m.
- Broader gold zones contain highly mineralised Stibnite zones.
- Dart Mining's exploration at Coonambula shows promising gold and antimony mineralization.
- Dart Mining is working in a JV with Great Divide Mining at Coonambula.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Great Divide Mining Ltd (GDM) ORDINARY FULLY PAID |
Materials |
$15 |
DTM: Highest Gold Results Received at Banshee Antimony Mine
|
15 Dec 2025 9:33AM |
$0.340 |
$0.325 |
fallen by
4.41%
|
|
GDM - Price-sensitive ASX Announcement
Full Release
Key Points
- Highest gold results at Banshee Antimony Mine
- Coonambula Antimony-Gold Project in Central Queensland
- Farm-In Joint Venture with Great Divide Mining
- Significant gold and antimony intersections
- Key results from drill hole CBADD002
- Broader gold zones containing stibnite
- Future exploration plans including IP survey and 3D modelling
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cauldron Energy Limited (CXU) ORDINARY FULLY PAID |
Energy |
$36 |
Application for quotation of securities - CXU
|
15 Dec 2025 9:33AM |
$0.020 |
$0.020 |
fallen by
0%
|
|
| Embark Early Education Limited (EVO) ORDINARY FULLY PAID |
Consumer Discretionary |
$113 |
Investor Presentation
|
15 Dec 2025 9:33AM |
$0.635 |
$0.615 |
fallen by
3.15%
|
|
| Ballymore Resources Limited (BMR) ORDINARY FULLY PAID |
Materials |
$64 |
Torpys drilling hints at major find, new zone discovered
|
15 Dec 2025 9:33AM |
$0.255 |
$0.310 |
risen by
21.57%
|
|
BMR - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant high-grade mineralization found at Torpy’s
- New zone discovered at Little Torpy’s
- Drill hole BTPRC004 yielded notable intersections
- Exploration part of Ballymore's growth strategy
- Favorable commodity market conditions with historic silver prices
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Peet Limited (PPC) ORDINARY FULLY PAID |
Real Estate |
$918 |
Response to Media Speculation
|
15 Dec 2025 9:33AM |
$1.905 |
$1.960 |
risen by
2.89%
|
|
| Horizon Minerals Limited (HRZ) ORDINARY FULLY PAID |
Materials |
$210 |
Senior Management Appointment
|
15 Dec 2025 9:31AM |
$0.068 |
$0.068 |
fallen by
0%
|
|
| Medallion Metals Limited (MM8) ORDINARY FULLY PAID |
Materials |
$227 |
Proposed issue of securities - MM8
|
15 Dec 2025 9:30AM |
$0.400 |
$0.370 |
fallen by
7.50%
|
|
| Anteris Technologies Ltd (AVR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$116 |
Board Resignation
|
15 Dec 2025 9:30AM |
$7.530 |
$6.900 |
fallen by
8.37%
|
|
| Medallion Metals Limited (MM8) ORDINARY FULLY PAID |
Materials |
$227 |
$60m Raise Fully Funds Ravensthorpe-Forrestania Development
|
15 Dec 2025 9:30AM |
$0.400 |
$0.370 |
fallen by
7.50%
|
|
MM8 - Price-sensitive ASX Announcement
Full Release
Key Points
- $60 million capital raising for Ravensthorpe-Forrestania development.
- $55 million placement from institutional investors.
- $5 million Share Purchase Plan for eligible shareholders.
- Funds to support engineering and infrastructure works.
- Feasibility study confirms project merits.
- Potential mine life extensions and exploration success.
- Final investment decision expected in early 2026.
- First production anticipated in early 2027.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Embark Early Education Limited (EVO) ORDINARY FULLY PAID |
Consumer Discretionary |
$113 |
Proposed issue of securities - EVO
|
15 Dec 2025 9:29AM |
$0.635 |
$0.615 |
fallen by
3.15%
|
|
| Embark Early Education Limited (EVO) ORDINARY FULLY PAID |
Consumer Discretionary |
$113 |
Placement
|
15 Dec 2025 9:29AM |
$0.635 |
$0.615 |
fallen by
3.15%
|
|
EVO - Price-sensitive ASX Announcement
Full Release
Key Points
- Embark Early Education Limited (ASX:EVO) completed a $12 million placement.
- The placement was to professional and sophisticated investors at $0.60 per share.
- The placement was at a discount to recent VWAP and closing prices.
- 20 million new shares were issued, increasing Embark's total share capital.
- Funds from the placement are for the takeover bid of Mayfield Childcare Limited and transaction costs.
- Unified Capital Partners Pty Ltd acted as the Sole Lead Manager and Bookrunner.
- New shares will be issued on 19 December 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Truscott Mining Corporation Limited (TRM) ORDINARY FULLY PAID |
Materials |
$16 |
Trading Halt
|
15 Dec 2025 9:29AM |
$0.084 |
$0.084 |
fallen by
0%
|
|
TRM - Price-sensitive ASX Announcement
Full Release
Key Points
- Truscott Mining Corporation Limited (TRM) requested a trading halt on its securities.
- The trading halt is pending an announcement related to a proposed capital raise.
- The halt will remain until the announcement is made or until normal trading resumes on 17 December 2025.
- TRM is not aware of any reason why the halt should not be granted or of any additional information needed to inform the market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Olympio Metals Limited (OLY) ORDINARY FULLY PAID |
Materials |
$6 |
Suspension from Quotation
|
15 Dec 2025 9:28AM |
$0.050 |
$0.050 |
fallen by
0%
|
|
OLY - Price-sensitive ASX Announcement
Full Release
Key Points
- Suspension of Olympio Metals Limited from quotation for not lodging periodic report.
- Suspension effective from December 15, 2025.
- Suspension under ASX Listing Rule 17.5.
- Reinstatement possible if report lodged before suspension imposition.
- Suspension also applies to Thorney Technologies Ltd.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Thorney Technologies Ltd (TEK) ORDINARY FULLY PAID |
Financials |
$43 |
Suspension from Quotation
|
15 Dec 2025 9:28AM |
$0.125 |
$0.115 |
fallen by
8%
|
|
TEK - Price-sensitive ASX Announcement
Full Release
Key Points
- Suspension date: 15 December 2025.
- Suspension due to non-compliance with periodic report lodging.
- Possible reinstatement if report lodged between 12 December and before suspension.
- ASX Listing Rule 17.5 applies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Clinical Labs Limited (ACL) ORDINARY FULLY PAID |
Health Care |
$539 |
Update - Notification of buy-back - ACL
|
15 Dec 2025 9:27AM |
$2.820 |
$2.780 |
fallen by
1.42%
|
|
| Bioxyne Limited (BXN) ORDINARY FULLY PAID |
Consumer Staple |
$94 |
Directors Change of Interest Notice X 2
|
15 Dec 2025 9:27AM |
$0.039 |
$0.043 |
risen by
10.26%
|
|
| American Rare Earths Limited (ARR) ORDINARY FULLY PAID |
Materials |
$204 |
Change of Director's Interest Notice
|
15 Dec 2025 9:27AM |
$0.360 |
$0.355 |
fallen by
1.39%
|
|
| Genetic Signatures Limited (GSS) ORDINARY FULLY PAID |
Health Care |
$55 |
Leadership Change at Genetic Signatures Limited
|
15 Dec 2025 9:27AM |
$0.260 |
$0.240 |
fallen by
7.69%
|
|
GSS - Price-sensitive ASX Announcement
Full Release
Key Points
- CEO Allison Rossiter is leaving Genetic Signatures in February 2026.
- The Board is searching for a new CEO.
- Interim leadership will be supported by Dr. Jenny Harry and Ms. Anne Lockwood.
- U.S.-based Directors will assist with U.S. sales activities.
- The company is also recruiting a new CFO.
- Leadership changes aim to strengthen management and U.S. market opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fortifai Ltd (FTI) ORDINARY FULLY PAID |
Communication Services |
$44 |
Proposed issue of securities - FTI
|
15 Dec 2025 9:26AM |
$0.200 |
$0.300 |
risen by
50%
|
|
Call 1300 880 160
Start a chat
Schedule a call
